Frequent intentional weight loss is associated with higher ghrelin and lower glucose and androgen levels in postmenopausal women

Nutrition Research

Volumn 30, Issue 3, 2010, Pages 163-170

  Hooper, Laura E ^a   Foster Schubert, Karen E ^a,b   Weigle, David S ^a   Sorensen, Bess ^b   Ulrich, Cornelia M ^a,b,c   McTiernan, Anne ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Dieting; Energy balance; Ghrelin; Leptin; Weight cycling; Women

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; ESTRADIOL; ESTROGEN; ESTRONE; GHRELIN; GLUCOSE; INSULIN; LEPTIN; PRASTERONE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C; TESTOSTERONE;

ADULT; AGED; ANALYTIC METHOD; ANDROGEN BLOOD LEVEL; ARTICLE; BODY WEIGHT; CHEMOLUMINESCENCE; CONTROLLED STUDY; EXERCISE TEST; FEMALE; FREQUENCY ANALYSIS; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HORMONE DETERMINATION; HUMAN; INCREASED APPETITE; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; RADIOIMMUNOASSAY; WEIGHT GAIN; WEIGHT REDUCTION;

AGED; ANDROGENS; APPETITE; BLOOD GLUCOSE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DEHYDROEPIANDROSTERONE; ENERGY METABOLISM; ESTROGENS; FEMALE; GHRELIN; HOMEOSTASIS; HUMANS; INSULIN; LEPTIN; MIDDLE AGED; POSTMENOPAUSE; TESTOSTERONE; WEIGHT GAIN; WEIGHT LOSS;

EID: 77952258736     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2010.02.002     Document Type: Article

References (48)

1. Neumark-Sztainer D. Obesity and eating disorder prevention: an integrated approach?. Adolesc Med 2003, 14:159-173.
2. Field A.E., Manson J.E., Taylor C.B., Willett W.C., Colditz G.A. Association of weight change, weight control practices, and weight cycling among women in the Nurses' Health Study II. Int J Obes Relat Metab Disord 2004, 28:1134-1142.
3. Bish C.L., Blanck H.M., Serdula M.K., Marcus M., Kohl H.W., Khan L.K. Diet and physical activity behaviors among Americans trying to lose weight: 2000 Behavioral Risk Factor Surveillance System. Obes Res 2005, 13:596-607.
4. Hjartaker A., Laake P., Lund E. Body mass index and weight change attempts among adult women. The Norwegian Women and Cancer Study. Eur J Public Health 2001, 11:141-146.
5. Serdula M.K., Mokdad A.H., Williamson D.F., Galuska D.A., Mendlein J.M., Heath G.W. Prevalence of attempting weight loss and strategies for controlling weight. Jama 1999, 282:1353-1358.
6. Fitzwater SL, Weinsier RL, Wooldridge NH, Birch R, Liu C, Bartolucci AA: Evaluation of long-term weight changes after a multidisciplinary weight control program. J Am Diet Assoc 1991;91:421-426, 429.
7. Wadden T.A., Frey D.L. A multicenter evaluation of a proprietary weight loss program for the treatment of marked obesity: a five-year follow-up. Int J Eat Disord 1997, 22:203-212.
8. Weight cycling. National Task Force on the Prevention and Treatment of Obesity. Jama 1994, 272:1196-1202.
9. Kroke A., Liese A.D., Schulz M., Bergmann M.M., Klipstein-Grobusch K., Hoffmann K., et al. Recent weight changes and weight cycling as predictors of subsequent two year weight change in a middle-aged cohort. Int J Obes Relat Metab Disord 2002, 26:403-409.
10. Lahti-Koski M., Mannisto S., Pietinen P., Vartiainen E. Prevalence of weight cycling and its relation to health indicators in Finland. Obes Res 2005, 13:333-341.
11. Wing R. Weight cycling in humans: a review of the literature. Ann Behav Med 1992, 14:113-119.
12. Shade E.D., Ulrich C.M., Wener M.H., Wood B., Yasui Y., Lacroix K., et al. Frequent intentional weight loss is associated with lower natural killer cell cytotoxicity in postmenopausal women: possible long-term immune effects. J Am Diet Assoc 2004, 104:903-912.
13. Meyer H.E., Tverdal A., Selmer R. Weight variability, weight change and the incidence of hip fracture: a prospective study of 39,000 middle-aged Norwegians. Osteoporos Int 1998, 8:373-378.
14. Dulloo A.G. A role for suppressed skeletal muscle thermogenesis in pathways from weight fluctuations to the insulin resistance syndrome. Acta physiologica Scandinavica 2005, 184:295-307.
15. Guagnano M.T., Ballone E., Pace-Palitti V., Vecchia R.D., D'Orazio N., Manigrasso M.R., et al. Risk factors for hypertension in obese women. The role of weight cycling. Eur J Clin Nutr 2000, 54:356-360.
16. Brownell K.D., Rodin J. Medical, metabolic, and psychological effects of weight cycling. Arch Intern Med 1994, 154:1325-1330.
17. Giusti V., Heraief E., Gaillard R.C., Burckhardt P. Predictive factors of binge eating disorder in women searching to lose weight. Eat Weight Disord 2004, 9:44-49.
18. Benini Z.L., Camilloni M.A., Scordato C., Lezzi G., Savia G., Oriani G., et al. Contribution of weight cycling to serum leptin in human obesity. Int J Obes Relat Metab Disord 2001, 25:721-726.
19. Wallner S.J., Luschnigg N., Schnedl W.J., Lahousen T., Sudi K., Crailsheim K., et al. Body fat distribution of overweight females with a history of weight cycling. Int J Obes Relat Metab Disord 2004, 28:1143-1148.
20. Graci S., Izzo G., Savino S., Cattani L., Lezzi G., Berselli M.E., et al. Weight cycling and cardiovascular risk factors in obesity. Int J Obes Relat Metab Disord 2004, 28:65-71.
21. Jeffery R.W., McGuire M.T., French S.A. Prevalence and correlates of large weight gains and losses. Int J Obes Relat Metab Disord 2002, 26:969-972.
22. Korkeila M., Rissanen A., Kaprio J., Sorensen T.I., Koskenvuo M. Weight-loss attempts and risk of major weight gain: a prospective study in Finnish adults. Am J Clin Nutr 1999, 70:965-975.
23. Vogels N., Diepvens K., Westerterp-Plantenga M.S. Predictors of long-term weight maintenance. Obes Res 2005, 13:2162-2168.
24. Field A.E., Malspeis S., Willett W.C. Weight cycling and mortality among middle-aged or older women. Arch Intern Med 2009, 169:881-886.
25. Strychar I., Lavoie M.E., Messier L., Karelis A.D., Doucet E., Prud'homme D., et al. Anthropometric, metabolic, psychosocial, and dietary characteristics of overweight/obese postmenopausal women with a history of weight cycling: a MONET (Montreal Ottawa New Emerging Team) study. J Am Diet Assoc 2009, 109:718-724.
26. Morton G.J., Cummings D.E., Baskin D.G., Barsh G.S., Schwartz M.W. Central nervous system control of food intake and body weight. Nature 2006, 443:289-295.
27. McTiernan A., Ulrich C.M., Yancey D., Slate S., Nakamura H., Oestreicher N., et al. The Physical Activity for Total Health (PATH) Study: rationale and design. Med Sci Sports Exerc 1999, 31:1307-1312.
28. Taylor H.L., Jacobs D.R., Schucker B., Knudsen J., Leon A.S., Debacker G. A questionnaire for the assessment of leisure time physical activities. J Chronic Dis 1978, 31:741-755.
29. McTiernan A., Tworoger S.S., Rajan K.B., Yasui Y., Sorenson B., Ulrich C.M., Chubak J., Stanczyk F.Z., Bowen D., Irwin M.L., et al. Effect of exercise on serum androgens in postmenopausal women: a 12-month randomized clinical trial. Cancer Epidemiol Biomarkers Prev 2004, 13:1099-1105.
30. Frank L.L., Sorensen B.E., Yasui Y., Tworoger S.S., Schwartz R.S., Ulrich C.M., et al. Effects of exercise on metabolic risk variables in overweight postmenopausal women: a randomized clinical trial. Obes Res 2005, 13:615-625.
31. McTiernan A., Tworoger S.S., Ulrich C.M., Yasui Y., Irwin M.L., Rajan K.B., et al. Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial. Cancer Res 2004, 64:2923-2928.
32. Foster-Schubert K.E., McTiernan A., Frayo R.S., Schwartz R.S., Rajan K.B., Yasui Y., et al. Human plasma ghrelin levels increase during a one-year exercise program. J Clin Endocrinol Metab 2005, 90:820-825.
33. McTiernan A., Sorensen B., Yasui Y., Tworoger S.S., Ulrich C.M., Irwin M.L., et al. No effect of exercise on insulin-like growth factor 1 and insulin-like growth factor binding protein 3 in postmenopausal women: a 12-month randomized clinical trial. Cancer Epidemiol Biomarkers Prev 2005, 14:1020-1021.
34. Bonora E., Targher G., Alberiche M., Bonadonna R.C., Saggiani F., Zenere M.B., et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000, 23:57-63.
35. Ogden C.L., Yanovski S.Z., Carroll M.D., Flegal K.M. The epidemiology of obesity. Gastroenterology 2007, 132:2087-2102.
36. Giudice L.C. Endometrium in PCOS: Implantation and predisposition to endocrine CA. Best practice & research 2006, 20:235-244.
37. Zawadzki J. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. Polycystic ovary syndrome, current issues in endocrinology and metabolism 1992, Blackwell Scientific Publications, Boston.
38. Barber T.M., Casanueva F.F., Karpe F., Lage M., Franks S., McCarthy M.I., et al. Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome. Eur J Endocrinol 2008, 158:511-516.
39. Glintborg D., Andersen M., Hagen C., Frystyk J., Hulstrom V., Flyvbjerg A., et al. Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls. Eur J Endocrinol 2006, 155:337-345.
40. Mitkov M., Pehlivanov B., Orbetzova M. Serum ghrelin level in women with polycystic ovary syndrome and its relationship with endocrine and metabolic parameters. Gynecol Endocrinol 2008, 24:625-630.
41. Moran L.J., Noakes M., Clifton P.M., Wittert G.A., Le Roux C.W., Ghatei M.A., et al. Postprandial ghrelin, cholecystokinin, peptide YY, and appetite before and after weight loss in overweight women with and without polycystic ovary syndrome. Am J Clin Nutr 2007, 86:1603-1610.
42. Schofl C., Horn R., Schill T., Schlosser H.W., Muller M.J., Brabant G. Circulating ghrelin levels in patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2002, 87:4607-4610.
43. Schwartz M.W., Woods S.C., Seeley R.J., Barsh G.S., Baskin D.G., Leibel R.L. Is the energy homeostasis system inherently biased toward weight gain?. Diabetes 2003, 52:232-238.
44. Tolle V., Kadem M., Bluet-Pajot M.T., Frere D., Foulon C., Bossu C., et al. Balance in ghrelin and leptin plasma levels in anorexia nervosa patients and constitutionally thin women. J Clin Endocrinol Metab 2003, 88:109-116.
45. Hansen D., Astrup A., Toubro S., Finer N., Kopelman P., Hilsted J., et al. Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial. Sibutramine Trial of Obesity Reduction and Maintenance. Int J Obes Relat Metab Disord 2001, 25:496-501.
46. Kotidis E.V., Koliakos G.G., Baltzopoulos V.G., Ioannidis K.N., Yovos J.G., Papavramidis S.T. Serum ghrelin, leptin and adiponectin levels before and after weight loss: comparison of three methods of treatment-a prospective study. Obesity surgery 2006, 16:1425-1432.
47. Leidy H.J., Gardner J.K., Frye B.R., Snook M.L., Schuchert M.K., Richard E.L., et al. Circulating ghrelin is sensitive to changes in body weight during a diet and exercise program in normal-weight young women. J Clin Endocrinol Metab 2004, 89:2659-2664.
48. Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J., Flegal K.M. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006, 295:1549-1555.